News

News

TARGET IV-NA Clinical Trial for the Firehawk™ Stent Completes the Last Enrollment -

MicroPort announced that the last patient enrollment for the TARGET IV...

MicroPort® Announces Important Follow-up Results at ESC Congress 2022 -

MicroPort® recently participated in the European Society of Cardiology...

MicroPort® MedBot™ Listed among the "50 Smartest Companies" in MIT Technology Review -

MicroPort® MedBot™ has been named by MIT Technology Review as one of t...

Endovastec™ Minos™ Abdominal Aortic Stent-Graft and Delivery System Receives Approval for Marketing in Colombia -

Endovastec™ recently received registration approval from the Colombian...

MicroPort® Announces 2022 Interim Results -

MicroPort® announced the interim results of the Group and its subsidia...

MicroPort EP Listed on the SSE STAR Market -

First innovative medical device company goes public on the STAR Market...

CardioFlow Medtech Announces 2022 Interim Results -

CardioFlow Medtech announced the interim results of the Company and it...

MicroPort NeuroTech™ Announces 2022 Interim Results -

MicroPort NeuroTech™ today announced the interim results of the Compan...

MicroPort NeuroTech™ NUMEN Coil Embolization System Receives Marketing Approval in Japan -

MicroPort NeuroTech™ has received marketing approval issued by Ministr...

MicroPort® MedBot™ Announces 2022 Interim Results -

MicroPort® MedBot™ today announced the interim results of the Company ...

Endovastec™ Announces 2022 Interim Results -

Endovastec™ today announced the interim results of the Company and its...

MicroPort NeuroTech™ APOLLO™ Intracranial Arterial Stent System Completed First Implantation in Brazil -

MicroPort NeuroTech™ recently announced that its independently develop...

VitaFlow Liberty™ by CardioFlow Medtech Obtains Marketing Approval in Colombia -

CardioFlow Medtech recently announced VitaFlow Liberty™ has received m...

MicroPort NeuroTech™ Completes First Implantations of NUMEN™ Coil Embolization System in Poland -

MicroPort NeuroTech™ recently announced that its independently develop...

MicroPort® MedBot™ JV’s R-ONE™ Vascular Interventional Surgical Robot Completes Registration Clinical Trial -

Shanghai Cathbot™ recently announced the completion of the clinical tr...

MSC Announces the First Clinical Use of TheFirst Rega™ MRI-Conditional Implantable Pacemaker in China -

MSC recently announced the first batch of the Rega™ MRI-conditional im...